EX-10.1 2 ex-101xjosephhaganannualsa.htm EXHIBIT 10.1 Exhibit


                                     Exhibit 10.1
Regulus Therapeutics Inc.

Joseph P. Hagan Yearly Discretionary Base Salary Increase

The Board of Directors (the “Board”) of Regulus Therapeutics Inc., upon the recommendation of the Compensation Committee of the Board, approved the increase of Mr. Hagan’s annual base salary to $427,450, effective January 1, 2017.